Ferroptosis: A Novel Mechanism in Diabetic Keratopathy

Li Huang1,2, Wentao Liang3, Tanzeel Huma3

  • 1Aier Eye Hospital, Jinan University, Guangzhou, Guangdong Province, China.

Abstract

Insights

Ferroptosis, an iron-dependent cell death, contributes to diabetic keratopathy (DK). Inhibiting ferroptosis with ferrostatin-1 (Fer-1) shows therapeutic potential for DK by reducing iron accumulation and oxidative stress.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Pathology

Background:

  • Diabetic keratopathy (DK) is a vision-impairing complication of diabetes mellitus.
  • The underlying mechanisms of DK, particularly the role of cell death pathways, are not fully understood.
  • Iron accumulation and oxidative stress are implicated in various diabetic complications.

Purpose of the Study:

  • To investigate the role of ferroptosis, an iron-dependent cell death, in diabetic keratopathy (DK).
  • To explore the therapeutic potential of ferroptosis inhibitors in treating DK.
  • To integrate evidence from human tissues, animal models, and in vitro studies.

Main Methods:

  • Examined iron accumulation in human diabetic and nondiabetic corneal tissues using Prussian blue staining.
  • Assessed corneal iron staining and transferrin receptor 1 (TfR1) expression in a diabetic mouse model.
  • Utilized primary human corneal epithelial cells exposed to high glucose to evaluate ferroptosis markers and the effect of ferrostatin-1 (Fer-1).

Main Results:

  • Diabetic corneas (human and mouse) exhibited significantly increased iron staining, correlating with elevated TfR1 expression in mice.
  • High glucose in vitro induced iron accumulation, increased oxidative stress (ROS, 4-hydroxynonenal), and altered antioxidant enzyme expression (decreased GPX4).
  • Ferrostatin-1 (Fer-1) treatment reduced iron accumulation and ROS, restored GPX4, and improved cell viability, proliferation, and migration.

Conclusions:

  • Ferroptosis is a key pathway implicated in the pathogenesis of diabetic keratopathy.
  • High glucose levels in DK likely trigger ferroptosis by increasing cellular iron and impairing antioxidant defenses.
  • Ferroptosis inhibitors, such as Fer-1, represent a promising therapeutic strategy for DK, warranting further investigation.